Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Development of marker guided therapeutic strategies in breast cancer

FY 2009-10

Summary
This project tackles one of the most important and current scientific questions in cancer research: can we match treatments to individual patients based on characteristics of the patient's genome? We will test this concept on breast cancer, a disease that affects one in nine Canadian women during their lifetime. The approach will involve analysing drug response data for a large number of clinically approved drugs in a large number of different breast tumour cells grown in the laboratory. Different tumours will be categorized as either responders or non-responders for each drug. We will then identify unique features of the patient's genomes that are associated with drug response. For example, we might identify a specific DNA mutation that predicts response to a particular drug. Such findings will form the basis for new diagnostic tests that can be tested in the clinic to identify those patients that will respond to a specific treatment and help identify the most appropriate treatment for each patient. The study will take advantage of recent advances in genome sequencing technology to profile numbers of tumours not previously possible. Such a large-scale approach is critical because of the large number of different breast cancer subtypes and the wide variability in drug response. If successful, this approach would identify simple screening tests that would help clinicians to better match patients with treatment, improving outcomes and reducing the unwanted side effects of our current 'one-size-fits-all' approach to chemotherapy.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
193774
Name
Griffith Obi L
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Development of marker guided therapeutic strategies in breast cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioinformatics; Breast Cancer; Cell Line; Chemotherapy; Drug Response; Genomics; Molecular Markers; Systems Biology
Abstract
This project tackles one of the most important and current scientific questions in cancer research: can we match treatments to individual patients based on characteristics of the patient's genome? We will test this concept on breast cancer, a disease that affects one in nine Canadian women during their lifetime. The approach will involve analysing drug response data for a large number of clinically approved drugs in a large number of different breast tumour cells grown in the laboratory. Different tumours will be categorized as either responders or non-responders for each drug. We will then identify unique features of the patient's genomes that are associated with drug response. For example, we might identify a specific DNA mutation that predicts response to a particular drug. Such findings will form the basis for new diagnostic tests that can be tested in the clinic to identify those patients that will respond to a specific treatment and help identify the most appropriate treatment for each patient. The study will take advantage of recent advances in genome sequencing technology to profile numbers of tumours not previously possible. Such a large-scale approach is critical because of the large number of different breast cancer subtypes and the wide variability in drug response. If successful, this approach would identify simple screening tests that would help clinicians to better match patients with treatment, improving outcomes and reducing the unwanted side effects of our current 'one-size-fits-all' approach to chemotherapy.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Griffith, Obi L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2009-10) | Canada Spends